Comparison of Cervical Laminectomy to Laminoplasty

November 3, 2017 updated by: Synthes USA HQ, Inc.

Comparison of Cervical Laminectomy to Cervical Laminoplasty* in Patients With Cervical Myelopathy or Myeloradiculopathy Due to Multiple Level Cervical Spinal Canal Stenosis * ARCH™ Fixation System by SYNTHES

The objective of this study is to compare the clinical and radiographic outcomes of multi-level laminectomy to multi-level laminoplasty in the treatment of patients with cervical myelopathy or myeloradiculopathy. The hypothesis for the study is that the laminoplasty group is not inferior to the laminectomy group.

Study Overview

Status

Terminated

Detailed Description

Historically, cervical laminectomy has been proven to be effective in the treatment of symptomatic patients with cervical myelopathy. This standard procedure is employed to accomplish posterior decompression of the cervical spinal cord in patients with multi-level cervical spinal stenosis who have normal or near normal cervical spinal curvature and alignment without associated instability. Laminoplasty was developed in Japan as an alternative to the laminectomy procedure with the intent to reduce post-operative morbidity after dorsal cervical spinal cord decompression, neck pain and to maintain the relative stability of the cervical spine after multi-level decompression.

The goal of both the laminoplasty and laminectomy procedures is to provide spinal cord decompression by enlargement of the spinal canal. A potential benefit of laminoplasty compared to laminectomy is to preserve stability and range of motion of the cervical spine without complete disruption/removal of the posterior laminae, spinous processes and interspinous ligamentous structures. Various authors have described different laminoplasty techniques; all preserve the lamina and expand the size of the spinal canal by fixing the freed or partially freed lamina in a more posterior position.

The primary study hypothesis is that, patients treated with laminoplasty with ARCH fixation (Treatment Group) have clinical and radiographic outcomes as assessed by valid outcomes measures, is not inferior to patients treated with laminectomy (Control Group)

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Beverly Hills, California, United States, 90211
        • Tower Orthopaedics
    • Connecticut
      • New Haven, Connecticut, United States, 06520
        • Yale University School Of Medicine
    • Missouri
      • Kansas City, Missouri, United States, 64132
        • Research Medical Center
      • Saint Louis, Missouri, United States, 63110
        • Washington University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria: All must be met for inclusion in the study.

  • The patient must be at least 18 years of age and have no evidence of developmental anomaly of the cranial cervical junction and/or cervical spine
  • The patient has the diagnosis of cervical myelopathy
  • The myelopathy or myeloradiculopathy requires a posterior cervical decompression of the spinal canal involving two or more contiguous intervertebral levels including and between C3 and C7
  • The patient signs the study informed consent form.

Exclusion Criteria:

  • Primary symptoms and signs of cervical radiculopathy (only) without myelopathy.
  • Presence of primary focal anterior compression of the cervical spinal cord.
  • Ossification of the ligamentum flavum.
  • Previous surgery of the cervical spine.
  • Tumor, infection, or trauma of the cervical spine or cord.
  • Segmental instability - Pregnant or interested in becoming pregnant during the study follow-up period.
  • Known sensitivity to device materials.
  • Currently being treated or intends to be treated postoperatively with other devices for the same disorder (e.g., electrical stimulation devices, pain control devices, etc.).
  • Currently a participant in any other study related to the treatment of cervical spinal disorders.
  • Prisoner
  • Mentally incompetent, or unable to comply with the follow up regime

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Laminectomy
Control
standard procedure
Active Comparator: Laminoplasty
Treatment group
Utilizing the ARCH Fixation System (Study device)
Other Names:
  • ARCH Fixation System

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Imrovement in Modified Japanese Orthopaedic Assessment (mJOA) Recovery Rate
Time Frame: 12 months
Number of participants who have mJOA Recovery Rate ≥0%. mJOA Recovery Rate is defined as: mJOA Recovery Rate = ((PostOp Score-PreOp Score)/(17 - Pre-Op Score))*100
12 months
Sagittal Angle Success
Time Frame: 12 months
Success defined as ≤ +15º (kyphosis) as indicated by a neutral lateral radiograph
12 months
Incidence of Surgical Interventions
Time Frame: up to 24 months
Success defined as a lack of revision, removal or addition of supplemental fixation.
up to 24 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Pain Scores on the Visual Analog Scale
Time Frame: Up to 24 months
Up to 24 months
Functional Improvement Using the Neck Disability Index (NDI)
Time Frame: up to 24 months
up to 24 months
Quality of Life Improvement Using the SF-12 Scale
Time Frame: up to 24 months
up to 24 months
Motor Deficit
Time Frame: up to 24 months
up to 24 months
Reflex Evaluation
Time Frame: up to 24 months
up to 24 months
Sensory Deficit
Time Frame: up to 24 months
up to 24 months
Range of Motion
Time Frame: up to 24 months
up to 24 months
Sagittal Canal Diameter
Time Frame: up to 24 months
up to 24 months
Extent of Spinal Canal/Cord Decompression
Time Frame: up to 24 months
up to 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Carl Lauryssen, MD, Tower Orthopaedics
  • Principal Investigator: Daniel Riew, MD, Washington University School of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2006

Primary Completion (Actual)

November 1, 2010

Study Completion (Actual)

November 1, 2010

Study Registration Dates

First Submitted

March 23, 2011

First Submitted That Met QC Criteria

March 28, 2011

First Posted (Estimate)

March 29, 2011

Study Record Updates

Last Update Posted (Actual)

December 7, 2017

Last Update Submitted That Met QC Criteria

November 3, 2017

Last Verified

October 1, 2017

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Diseases

Clinical Trials on laminectomy

3
Subscribe